Monolithic India Pharmaceuticals Private Limited

Monolithic India Pharmaceuticals Private Limited - chemicals in Noida, Uttar Pradesh, India. Directors, charges & compliance details.
CIN U24297UP2021PTC155966 Incorporated 25 November 2021 ROC Uttar Pradesh HQ Noida, Uttar Pradesh, India
Active Private Limited Company chemicals MSME · Micro
Revenue · FY 2024
₹3.87 Lakh
▲ 46% YoY
Net loss · FY 2024
₹86,460
Net margin -22.3%
EBITDA · FY 2024
-₹84,074
EBITDA margin -21.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Monolithic India Pharmaceuticals Private Limited

Data last updated:

Monolithic India Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 25 November 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24297UP2021PTC155966.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Lokesh Kumar Jha and Prashant Singh.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No. 3B Plot No. A1 3rd Floor Sector – 10 Noida, Uttar Pradesh, India – 201301.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.87 Lakh, a growth of 46% compared to the previous year. For the same year it recorded a net loss of ₹86,460 (net margin -22.3%) and EBITDA of -₹84,074 (EBITDA margin -21.7%).

Monolithic India Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0037067).

Company details

CIN U24297UP2021PTC155966
Registration Number 155966
Incorporation Date 25 November 2021
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0037067

Recognitions & Rankings of Monolithic India Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-UP-28-0037067

Contact details

Monolithic India Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh.

  • Registered Address
    Office No. 3B Plot No. A1 3rd Floor Sector – 10 Noida, Uttar Pradesh, India – 201301
  • Industry
    Chemicals, Other Chemical Product, Manufacturing, Chemical Products Or Preparations Of A Kind Used In The Textiles
Comprehensive company report
Monolithic India Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Monolithic India Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Monolithic India Pharmaceuticals Private Limited, buy the company report.

Financials of Monolithic India Pharmaceuticals Private Limited

FY 2024 filings available

Monolithic India Pharmaceuticals Private Limited reported revenue of ₹3.87 Lakh (up 46% YoY) for FY 2024.

Revenue · FY 2024
₹3.87 Lakh ▲ 46%
Net loss · FY 2024
₹86,460 margin -22.3%
EBITDA · FY 2024
-₹84,074 margin -21.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 46%
EBITDA CAGR growth
1 year
▲ 78%

Revenue rose 46% in the latest year. EBITDA rose 78% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹84,074
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹86,460
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-21.7%
Net Profit Margin-22.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Monolithic India Pharmaceuticals Private Limited, buy the company report.

Board of directors of Monolithic India Pharmaceuticals Private Limited

Monolithic India Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Lokesh Kumar JhaDirector25 Nov 20214 Years 11 MonthsCurrent
Prashant SinghDirector25 Nov 20214 Years 11 MonthsCurrent
Amish MishraDirector25 Nov 20214 Years 11 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Monolithic India Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Monolithic India Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Monolithic India Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Amish Mishra was appointed as Director on 25 Nov 2021.

AGM
Monolithic India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Monolithic India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttar Pradesh Ii.
Appointed
Amish Mishra was appointed as Director.
Appointed
Lokesh Kumar Jha was appointed as Director.
Appointed
Prashant Singh was appointed as Director.
Incorporation
25 Nov 2021
Monolithic India Pharmaceuticals Private Limited was registered on 25 Nov 2021 with Roc Uttar Pradesh Ii & aged 4 years 11 months as per MCA records.

Frequently asked questions

Monolithic India Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 25 November 2021 (5+ years old) and is registered under CIN U24297UP2021PTC155966.

Monolithic India Pharmaceuticals has 3 current directors:

The latest financial statements of Monolithic India Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Monolithic India Pharmaceuticals is U24297UP2021PTC155966. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Monolithic India Pharmaceuticals was incorporated on 25 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

Amish Mishra was appointed as Director on 25 Nov 2021. Lokesh Kumar Jha was appointed as Director on 25 Nov 2021. Prashant Singh was appointed as Director on 25 Nov 2021.

Yes, Monolithic India Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0037067).

The registered office of Monolithic India Pharmaceuticals is at Office No. 3B Plot No. A1 3rd Floor Sector – 10 Noida, Uttar Pradesh, India – 201301.

Monolithic India Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.

Monolithic India Pharmaceuticals can be reached at its registered office: Office No. 3B Plot No. A1 3rd Floor Sector – 10 Noida, Uttar Pradesh, India – 201301.